Clinical Trial Update: Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluates bevacizumab-based chemotherapy adapted to bevacizumab pharmacokinetics for first-line treatment of unresectable metastatic colorect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Unresectable Metastatic Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING